Abstract
Introduction

Ž .
Nitric oxide NO has a key role in many physiological processes including the regulation of cardiovascular function through effects on blood pressure, flow, vascular proliferation, platelet function, and the peripheral and cen-Ž w x. tral nervous systems for recent reviews, see Refs. 1,2 .
Ž . Three main isoforms of NO synthase NOS have been described. The constitutive isoforms NOS1 and NOS3, originally found in neurones and endothelial cells respectively, are also expressed in several other tissues, e.g., w x NOS3 in cardiac myocytes 3 . The inducible isoform NOS2 is usually expressed only in response to certain ) Ž . Ž . Corresponding author. Tel.: q44 1222 742338; Fax: q44 1222 743500; E-mail: shaham2@cf.ac.uk stimuli, e.g., cytokines. Although NOS3 is ''constitutively'' expressed, significant changes in gene expression have been reported in many tissues in response to various physiological and pathophysiological stimuli. An increase in NOS3 expression in endothelial cells in vitro occurs in w x response to chronic fluid shear stress 4 , exposure to Ž .w x transforming growth factor b TGF b 5 , or during cell w x proliferation 6 , while chronic exercise increases NOS3 w x mRNA in endothelial cells in vivo 7 . NOS3 is also upregulated in vascular and non-vascular tissues during w x pregnancy 8 . On the other hand, endothelial NOS3 ex-Ž pression is decreased by tumour necrosis factor-a which
. w x induces NOS2 in many tissues 9 , oxidized low-density Time for primary review 21 days.
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at Pennsylvania State University on February 23, 2013 http://cardiovascres.oxfordjournals.org/ Downloaded from ( )w x w x lipoprotein 10 , and hypoxia in some studies 11 , while elevation of cAMP is reported to reduce the expression of NOS3 in rat cardiac myocytes both in vitro and in vivo w x 12 .
Recent studies in isolated preparations as well as human subjects indicate a physiological role for NO in the regula-Ž tion of cardiac contractile function for recent reviews, see w x. Refs. 13, 14 . A number of different effects of NO on Ž . contractile function have been reported, including i an enhancement of myocardial relaxation and diastolic funcw x Ž . tion 13,15-18 , ii modulation of b-adrenergic inotropic w x Ž . responses 3,19,20 , iii interaction with the Frank-Starling w x Ž . response 21 , and iv modulation of the force-frequency w x relationship 22,23 . NO may also have anti-hypertrophic w x activity 24 , and has been shown to reduce oxygen conw x sumption 25 . The main physiological source of NO in the heart with respect to contractile function is probably NOS3 Ž . in coronary microvascular endothelial cells CMEC and in cardiac myocytes, although NOS3 in endocardial endothelial cells and NOS1 in neurones could also play a role w x 13,14 . There is very little published data on the molecular regulation of NOS3 in the heart in pathological states. The focus of the present study was hypertensive cardiac hypertrophy. Previous studies have suggested abnormalities of coronary endothelial function in hypertensive hypertrophy. NO-dependent regulation of coronary vascular resistance is Ž . w x abnormal in spontaneously hypertensive rats SHR 26 . In human subjects with hypertension and LV hypertrophy, the coronary flow response to acetylcholine is impaired, w x probably reflecting reduced release or activity of NO 27 . On the other hand, a recent study reported that Ca 2q -dependent NOS biochemical activity was increased in carw x diac tissue of SHR 28 . In the present study, we sought to examine whether the cell-specific expression of NOS3 was altered in the hypertrophied heart of SHR. We chose to Ž . study young 12 week old SHR, that is, at a stage when w x there is significant LV hypertrophy 29,30 and evidence of Ž . w x contractile especially diastolic dysfunction 31,32 , but as yet no marked degree of extracellular fibrosis or features w x of decompensation 29 .
Methods
The investigation conformed with the Guide for the Care and Use of Laboratory Animals published by the US Ž National Institutes of Health NIH Publication No. 85-23, . revised 1985 . Male SHR and age-and sex-matched normotensive Wistar rats were obtained from Charles River Ž . Breeding Laboratories UK , and housed under identical conditions. All animals were studied at 12 weeks age. They were sacrificed by intraperitoneal overdose of sodium pentobarbitone and hearts rapidly excised into oxygenated physiological saline solution. A total of 29 SHR and 28 Wistar rats were used in these studies.
Isolation of cardiac myocytes
LV myocytes were isolated by collagenase digestion of w x hearts, as described previously 33 . Briefly, hearts were mounted on a Langendorff apparatus and perfused at 9 mlrmin and 378C with a series of solutions based on an Ž . ''isolation solution'' of the following composition in mM : NaCl 130, KCl 5.4, MgCl 1.4, NaH PO 0. 4 Ž . mgrml and protease Sigma type 14; 0.01 mgrml for 9-12 min. The LV was dissected and finely chopped in an enzyme-containing solution with bovine serum albumin Ž . BSA 1%, and gently agitated in a water bath at 378C. Aliquots of the cell suspension were examined every 5 min until a ) 80% yield of rod-shaped cells with a clear striation pattern was obtained. Myocytes were collected by filtration through nylon gauze and gentle centrifugation, followed by passage through two 5% BSA density gradients, and re-suspension in isolation solution containing CaCl 500 mM. The final purity of myocyte preparations 2 was ) 95% rod-shaped cells with a clear striation pattern. mgrml. Cell suspensions were plated in 75 cm 2 tissue culture flasks and incubated at 378C. After 1 h, unattached cells and debris were washed off with 0.9% saline. Cells were either used for RNA isolation at this stage, or following a period of culture for 7-14 days. Cultured cells formed confluent monolayers with a ''cobblestone'' morphology within about 5-7 days. For more prolonged culture, cells were trypsinised and subcultured in fresh flasks.
Isolation of coronary microÕascular endothelial cells
Cells were characterised as endothelial by the uptake of w x fluorescently labelled acetylated LDL 34 . The endothelial cell population obtained with this method may include some endocardial endothelial cells and some endothelial cells from larger coronary vessels, but the statistical average represents predominantly CMEC since the vast majority of all cardiac endothelial cells are found in small w x vessels and the capillary bed 34 . In keeping with this, cells stained positively with the microvascular-specific w x lectin Lycopersicon esculentum lectin 35 , negatively for a-smooth muscle actin, and rapidly formed capillary-like tubes on the basement membrane preparation Matrigel w x Ž 36 . No cardiac myocytes easily identifiable by their size . and characteristic morphology were observed in endothelial cell isolates.
Western blotting
Cells were washed twice in ice-cold PBS prior to lysis in 1 ml of boiling lysis solution containing 1% SDS and 10 mM Tris pH 7.4. After scraping the cells into this solution and further boiling for 5 min, insoluble material was removed by centrifugation. Protein concentration was mea-Ž . sured in an aliquot using a micro BCA kit Pierce . Equal amounts of protein were run on 8% SDS-polyacrylamide gels and electroblotted onto nitrocellulose membrane. Equal transfer among lanes was confirmed by reversible staining Ž . with Ponceau S Sigma . The membrane was incubated with a mouse monoclonal antibody raised against a Ž . polypeptide amino acid residues 1030-1209 of the hu-Ž . man NOS3 protein Transduction Labs. . The secondary antibody was a sheep horseradish peroxidase-linked anti-Ž . mouse antibody Amersham . Blots were assessed by densitometry of bands, with subtraction of the background counts measured outside loaded lanes. The values for SHR samples were normalized by the mean value obtained with control Wistar rat samples.
RNA isolation, semi-quantitatiÕe RT-PCR and Southern blotting
Total RNA was isolated from cardiac myocytes or w x CMEC by extraction with guanidinium isothiocyanate 37 . In view of the relatively low level of NOS3 expression in w x cardiac myocytes 3 and the requirement to pool freshly isolated CMEC from at least 4-6 hearts per experiment, RT-PCR and Southern blotting were used in these studies. First strand cDNA synthesis was performed using 5 mg total RNA, quantified spectrophotometrically, in the pres-Ž . Ž ence of random hexamers 500 ng, Promega , dNTPs 10 . Ž . mM each, Boehringer , Tris-HCl 10 mM pH 8.4 , KCl 50 Ž . mM, MgCl 2.5 mM, and RNase inhibitor 33 U Promega . 2 The reaction mixture was preincubated at 708C for 3 min followed by cooling on ice prior to addition of Moloney Ž murine leukemia virus reverse transcriptase 200 U, Gibco-. BRL . The RT reaction was performed at 428C for 90 min. Primers for amplification of a 324-bp rat NOS3 PCR w x X product were based on published sequences 3 : 5 -GGGC-CAGGGTGATGAGCTCTG-3 X and 5 X -CCCTCCTGGCT-X Ž . TCCAGTGTCC-3 sense and antisense respectively . A 996-bp rat GAPDH cDNA PCR product, as a reference cellular transcript, was amplified using the following primers: 5 X -GTGAAGGTCGGTGTCAAC-3 X and 5 X -CTC-X Ž CTTGGAGGCCATGT-3 sense and antisense respec-
. w x tively 38 . PCR reactions were carried out in 100 ml final Ž . volumes containing RT reaction 2 ml , sense and anti- Fig. 2 ; n s 25 for GAPDH comprised 1 min at 948C, 1 min at 658C, and 2 min at 728C, followed by a 10 min extension reaction at 728C. The same preparation of RNA was reverse transcribed and amplified two to three times to confirm reproducibility of the analysis.
PCR products were separated on 1.2% agarose gels Ž . . mCi P dCTP ml 3000 Ci mmol ; Amersham . These probes consisted of the PCR fragments described above, amplified from rat heart tissue and sequenced. Filters were washed to a final stringency of 0.1 = SSCr0.1% SDS at 658C, and exposed to KODAK X-100 XAR film with intensifying screens at y708C. Quantification of autoradiograms was performed by densitometry using an Im-Ž . age Quant Densitomer Molecular Dynamics , and values w x for NOS3 were normalized with respect to GAPDH 39,40 .
Statistics
Data are presented as mean " SEM. Comparisons were performed by a two-tailed Student's unpaired t-test, and P -0.05 considered statistically significant.
Results
The LVrbody weight ratios were significantly greater in 12 week old SHR compared to normotensive Wistar rats Ž3.84 " 0.20 mgrg compared to 2.82 " 0.06 mgrg; n s 9 . each; P -0.002 , indicating significant LV hypertrophy and consistent with other published data in this model Ž w x. e.g., Ref. 30 . Fig. 1 shows the results of Western analysis for NOS3 protein, using a NOS3-specific monoclonal antibody, in SHR and Wistar cardiac myocytes. A 140 kDa protein w x band compatible with NOS3 1 was identified in the whole cell lysate of both groups. The levels of NOS3 protein were significantly lower in SHR relative to Wistar Ž .
Ž . Ž . Ž cardiac myocytes SHR 14.5 " 0.11% of the level in Wis-. tar myocytes; n s 6 SHR and 6 Wistar hearts; P -0.001 . Fig. 2 indicates that the levels of NOS3 protein in freshly isolated CMEC were similar in SHR and Wistar rats, in contrast to the downregulation of NOS3 in SHR cardiac myocytes. The mean level of NOS3 protein in SHR CMEC Ž was 100 " 1.4% of the level in Wistar CMEC n s 8 SHR . and 8 Wistar hearts each; P s NS .
In order to investigate the underlying cause of this downregulation of myocyte NOS3 protein, we studied the expression of NOS3 mRNA. Using species-specific oligow x nucleotide primers 3 , a 324-bp NOS3 product was ampli-Ž fied by RT-PCR from both cardiac myocytes 1 Wistar . Ž . Ž heart and freshly isolated CMEC 4 Wistar hearts X vitrogen and transformation into E. coli INVa F competent cells. Interestingly, we observed that the level of expression of NOS3 mRNA was significantly reduced in Ž . cultured compared to freshly isolated CMEC Fig. 3a , so that experiments were restricted to freshly isolated CMEC.
The expression of NOS3 mRNA, normalised for GAPDH mRNA, was significantly increased in cardiac myocytes isolated from SHR compared to Wistar rats by Ž . RT-PCR-Southern blotting Fig. 4 . The level of expression of GAPDH was unaltered. This difference was also confirmed by examining PCR products after varying degrees of amplification. As shown in Fig. 5, a NOS3 transcript was easily apparent in SHR myocytes after 30 cycles of amplification, whereas in Wistar myocytes this was only the case after 35 cycles of amplification.
In contrast to the findings in cardiac myocytes, the level of expression of NOS3 mRNA, normalized for GAPDH, was similar in freshly isolated CMEC from SHR and Ž Wistar rat hearts SHR 1.25 " 0.085 fold that in Wistar . CMEC; n s 6 hearts each; P s NS .
Discussion
The ''constitutive'' endothelial-type isoform of NO synthase, NOS3, is expressed in a number of cell types in the mammalian heart, notably the endothelial cells of the coronary vasculature and cardiac myocytes. Recent studies from a number of laboratories including our own indicate that NO can modulate cardiac contractile function. It has become clear that both CMEC-derived NO and myocytederived NO, acting in a paracrine and autocrinerintracrine fashion respectively, may be involved in the physiological w x regulation of contractile and other functions 13,14 . It seems likely that NO derived from these different cellular sources may have differing effects on cardiac myocytes in Ž . situ because of spatial factors e.g., diffusion distance , Ž varying levels of expression greater in CMEC than in . cardiac myocytes , and potential differences in the stimuli that evoke release of NO. Possible changes in the expression of NOS3 in the heart in pathological states and the consequences of such alterations, particularly for contractile function, have not so far been characterised. In the present study, we show that the cardiac expression of NOS3 protein is significantly reduced in a cell-specific Ž . manner i.e., in cardiac myocytes but not in CMEC in a genetic model of hypertensive left ventricular hypertrophy, namely the SHR. At the stage that the SHR animals were Ž . studied i.e., 12-week-old , they are known to have significant hypertension and compensated LV hypertrophy but as yet no evidence of marked extracellular fibrosis nor of w x decompensation into heart failure 29,30 . Contractile dysfunction at this stage is reported to be characterised by a significant rightward shift of the Frank-Starling curve, particularly at lower filling pressures, compatible with diastolic dysfunction and increased myocardial diastolic w x stiffness 31,32,41 . The fact that the changes in NOS3 protein and mRNA in SHR compared to Wistar control rats were selective for cardiac myocytes, whereas levels of NOS3 in CMEC were similar between the two groups, suggests that this difference is indeed related to the myocardial abnormalities rather than being simply due to other possible differences between these animal strains. This contention is also supported by previous studies which have demonstrated specific cardiac abnormalities in SHR compared to normotensive Wistar rats and related w x these to the hypertrophy of SHR hearts 42-44 . Decreased expression of NOS3 protein in cardiac myocytes could have a number of functional effects. Although hypertensive LV hypertrophy is initially an adaptive response that normalises wall stress and preserves baseline contractile function, it leads to contractile dysfunction Ž . e.g., abnormal myocardial relaxation and other abnormalities such as energy imbalance. A reduction of NOS3 protein in cardiac myocytes in the hypertrophied heart Ž . could a contribute to the abnormalities of myocardial w x Ž . relaxation and diastolic function 15-18,21 , b alter rew x Ž . sponsiveness to b-adrenergic stimulation 3,19,20 , and c increase myocardial oxygen consumption, thereby worsenw x ing oxygen supply-demand balance 25 . It is interesting that the main contractile abnormalities in young SHR are a significant rightward shift of the Frank-Starling curve and w x an increase in myocardial diastolic stiffness 31,32,41 , given that NOS3 is known to enhance myocardial relaxw x ation and diastolic function 13,15-18 and to augment the w x Frank-Starling response 21 . Although no change in NOS3 was observed in CMEC, the amount of NO from this source reaching cardiac myocytes may also conceivably be reduced in the hypertrophied heart as a consequence of the increased diffusion distances between EC and cardiac myocytes.
Unexpectedly, the reduction in NOS3 protein in SHR cardiac myocytes was not accompanied by a reduction in NOS3 mRNA, but rather an increase. This finding clearly indicates that the reduction in NOS3 protein levels does not result from reduced transcription. Possible explanations for the reduction in NOS3 protein despite abundant message include alterations in translational efficiency, a deficiency in essential co-factors for protein synthesis and Ž . stability e.g., haem, FAD, FMN, calmodulin , abnormal post-translational processing, andror other changes in NOS3 protein stability. In this regard, Belhassen and w x coworkers 45 have recently reported that the intracellular Ž . post-translational processing in particular, palmitoylation of NOS3 in rat cardiac myocytes, and its subsequent targeting to sarcolemmal caveolae, are both influenced by changes in intracellular cAMP -effects which may be applicable to the hypertrophied heart. There are several other examples in the literature of a similar discrepancy between mRNA and protein expression; for instance, with respect to expression of cytochrome b558 in Epstein-Barr w x virus-immortalized B-lymphocytes 46 .
The basis for the increase in NOS3 mRNA in SHR myocytes was not defined in this study. Several recent studies indicate that the expression of NOS3, a ''constitutive'' protein, is subject to significant transcriptional regulation by various physiological and pathophysiological stimuli. The promoter of the NOS3 gene contains shear stress response elements as well as a number of putative binding domains that may be regulated by various transcription factors. In particular, an AP-1 and a nuclear Ž . factor-1 NF-1 -like binding site have been identified. It has been suggested that protein kinase C-mediated signalling pathways may regulate NOS3 expression through the AP-1 site, whereas cAMP and TGF b may act through w x the NF-1 binding site 47 . In this regard, it may be relevant that protein kinase C-mediated signalling pathways are implicated in the development of cardiac hyperw x trophy 48 .
We observed no significant differences in the level of NOS3 mRNA and protein in SHR CMEC relative to Wistar controls in this study. At first sight, this might suggest that alterations in NOS3 do not contribute to coronary Õascular abnormalities in SHR, and would seem to be in conflict with previous studies that have reported reduced endothelium-dependent coronary vascular relaxw x ation in hypertension and LV hypertrophy 26,27,49 . However, the biological actions of NO may be reduced Ž . even with normal levels of protein if a there is increased inactivation of NO, e.g., by reactive oxygen species, Ž . andror b NOS3 protein actiÕity is impaired, e.g., be-Ž . cause of a deficiency of substrate L-arginine or essential co-factors such as tetrahydrobiopterin. Thus, the findings of the present study with respect to NOS3 in CMEC are not inconsistent with reports of reduced endothelium-dependent coronary vascular relaxation in hypertension and w x LV hypertrophy. On the other hand, Nava et al. 28 recently reported an increased biochemical activity of Ca 2q -dependent NOS in cardiac endothelium of SHR. With respect to biochemical assays of NOS activity, it is important to remember that these are performed in the w x presence of excess substrate and co-factors 28 . Thus, these in vitro assays may not necessarily reflect the true level of NOS3 activity in vivo, especially if there is a deficiency of substrate andror co-factors or an increased inactivation of NO.
The NO pathway appears to be involved in many aspects of physiological blood pressure control and possiw x bly in hypertension 1,2 . Transgenic mice that lack the at Pennsylvania State University on February 23, 2013 http://cardiovascres.oxfordjournals.org/ Downloaded from ( )w x NOS3 gene develop significant systemic hypertension 50 . Abnormalities of NO-dependent regulation of vascular tone have been described both in peripheral vessels and the coronary circulation in hypertension and LV hypertrophy w x 26,27,49,51 . In the present study, we have documented a selective dysregulation of NOS3 in the cardiac myocytes Ž . but not CMEC of SHR, which may be relevant to the pathophysiology of myocardial dysfunction associated with LV hypertrophy. It should be noted that the effects of NO Ž . on contractile and other function will also be influenced by other factors such as substrate and co-factor availability, redox state, the presence or absence of reactive oxygen species, and the activities of downstream signalling pathways such as the cGMP system. Furthermore, the findings of this study cannot necessarily be extrapolated to other types of LV hypertrophy. Nevertheless, this study suggests that dysregulation of cardiac myocyte NOS3 may be relevant in the pathophysiology of hypertensive LV hypertrophy and further investigation of the functional effects of NO on myocardium in this condition are indicated.
